Leading Research to Understand, Treat, and Prevent Infectious, Immunologic, and Allergic Diseases
Scientists Identify Potential Vaccine Candidate for Pediatric Malaria
A group of researchers that includes scientists from NIAID have identified a substance, or antigen, that generates antibodies that can hinder the ability of malaria parasites to multiply, which may protect against severe malaria infection. The antigen, known as PfSEA-1, was associated with reduced parasite levels among children and adults in malaria-endemic areas. The discovery of PfSEA-1 could be a critical addition to the limited pool of antigens currently used in candidate malaria vaccines.
The findings appear in the May 23 issue of Science. For more information, visit: http://www.niaid.nih.gov/news/